Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity
Shihyin Tsai, … , Albert R. La Spada, Brian K. Kennedy
Shihyin Tsai, … , Albert R. La Spada, Brian K. Kennedy
Published June 29, 2015
Citation Information: J Clin Invest. 2015;125(8):2952-2964. https://doi.org/10.1172/JCI77361.
View: Text | PDF
Research Article Metabolism

Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity

  • Text
  • PDF
Abstract

Eukaryotic translation initiation factor 4E–binding protein 1 (4E-BP1) is a key downstream effector of mTOR complex 1 (mTORC1) that represses cap-dependent mRNA translation initiation by sequestering the translation initiation factor eIF4E. Reduced mTORC1 signaling is associated with life span extension and improved metabolic homeostasis, yet the downstream targets that mediate these benefits are unclear. Here, we demonstrated that enhanced 4E-BP1 activity in mouse skeletal muscle protects against age- and diet-induced insulin resistance and metabolic rate decline. Transgenic animals displayed increased energy expenditure; altered adipose tissue distribution, including reduced white adipose accumulation and preserved brown adipose mass; and were protected from hepatic steatosis. Skeletal muscle–specific 4E-BP1 mediated metabolic protection directly through increased translation of peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α) and enhanced respiratory function. Non–cell autonomous protection was through preservation of brown adipose tissue metabolism, which was increased in 4E-BP1 transgenic animals during normal aging and in a response to diet-induced type 2 diabetes. Adipose phenotypes may derive from enhanced skeletal muscle expression and secretion of the known myokine FGF21. Unlike skeletal muscle, enhanced adipose-specific 4E-BP1 activity was not protective but instead was deleterious in response to the same challenges. These findings indicate that regulation of 4E-BP1 in skeletal muscle may serve as an important conduit through which mTORC1 controls metabolism.

Authors

Shihyin Tsai, Joanna M. Sitzmann, Somasish G. Dastidar, Ariana A. Rodriguez, Stephanie L. Vu, Circe E. McDonald, Emmeline C. Academia, Monique N. O’Leary, Travis D. Ashe, Albert R. La Spada, Brian K. Kennedy

×

Figure 6

Increased FGF21 expression from 4E-BP1–activated skeletal muscle and altered expression of genes involved in fat metabolism in adipose and liver tissues.

Options: View larger image (or click on image) Download as PowerPoint
Increased FGF21 expression from 4E-BP1–activated skeletal muscle and alt...
(A) RT-PCR quantification of myokine genes (n = 4) and (B) Western blots of quadriceps skeletal muscles (Qm) from 6-month-old male mice fed normal chow to detect FGF21 expression. (C) Quantification of FGF21 signaling from B normalized to the housekeeping gene, HSP90. P values were calculated by 1-tailed unpaired Student’s t test. (D) Serum FGF21 level in fasted 6-month-old mice (the number of mice analyzed is indicated in bars). (E) Western blots of quadriceps muscles from 6-month-old male mice fed a normal chow diet to detect PPARγ expression in adipose tissues. WAT, white adipose tissue; BAT, brown adipose tissue. RT-PCR quantification of genes involved in fatty acid metabolism and thermogenesis in (F) white adipose tissue and (G) brown adipose tissue. P values from FGF21 ELISA and RT-PCR were assessed by 2-way ANOVA. Bonferroni post-tests were used to compare replicate means by row. *P < 0.05; ***P < 0.001. RT-PCR samples were from n = 4 per genotype.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts